Neuropeptide interactions and REM sleep: A role for Urotensin II?

Peptides

Volumn 29, Issue 5, 2008, Pages 845-851

  de Lecea, Luis ^a   Bourgin, Patrice ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Acetylcholine; Blood flow; Laterodorsal tegmentum; Pedunculopontine nucleus; Sleep; Urotensin related peptide; Vasoactive; Wakefulness

Indexed keywords

NEUROPEPTIDE; OREXIN; UROTENSIN II;

ARTICLE; BRAIN STEM; DRUG MECHANISM; HEART; HUMAN; MICROVASCULATURE; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REM SLEEP; SPINAL CORD;

ANIMALS; NEURONS; NEUROPEPTIDES; SLEEP, REM; UROTENSINS; VASOCONSTRICTOR AGENTS;

EID: 42049091449     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.02.009     Document Type: Article

References (79)

1. Ahnaou A., Basille M., Gonzalez B., Vaudry H., Hamon M., Adrien J., et al. Long-term enhancement of REM sleep by the pituitary adenylyl cyclase-activating polypeptide (PACAP) in the pontine reticular formation of the rat. Eur J Neurosci 11 (1999) 4051-4058
2. Ahnaou A., Laporte A.M., Ballet S., Escourrou P., Hamon M., Adrien J., et al. Muscarinic and PACAP receptor interactions at pontine level in the rat: significance for REM sleep regulation. Eur J Neurosci 12 (2000) 4496-4504
3. Ahnaou A., Yon L., Arluison M., Vaudry H., Hannibal J., Hamon M., et al. Immunocytochemical distribution of VIP and PACAP in the rat brain stem: implications for REM sleep physiology. Ann N Y Acad Sci 1070 (2006) 135-142
4. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 (1999) 282-286
5. Baghdoyan H.A., Lydic R., Callaway C.W., and Hobson J.A. The carbachol-induced enhancement of desynchronized sleep signs is dose dependent and antagonized by centrally administered atropine. Neuropsychopharmacology 2 (1989) 67-79
6. Behm D.J., Herold C.L., Ohlstein E.H., Knight S.D., Dhanak D., and Douglas S.A. Pharmacological characterization of SB-710411 (Cpa-c[d-Cys-Pal-d-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist. Br J Pharmacol 137 (2002) 449-458
7. Bernard R., Lydic R., and Baghdoyan H.A. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation. J Pharmacol Exp Ther 317 (2006) 163-171
8. Bohm F., and Pernow J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 135 (2002) 25-27
9. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
10. Bourgin P., Ahnaou A., Laporte A.M., Hamon M., and Adrien J. Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors. Neuroscience 89 (1999) 291-302
11. Bourgin P., Escourrou P., Gaultier C., and Adrien J. Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport 6 (1995) 532-536
12. Bourgin P., Huitrón-Reséndiz S., Spier A., Fabre V., Morte B., Criado J., et al. Hypocretin-1 modulates REM sleep through activation of locus coeruleus neurons. J Neurosci 20 (2000) 7760-7765
13. Bourgin P., Lebrand C., Escourrou P., Gaultier C., Franc B., Hamon M., et al. Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat. Neuroscience 77 (1997) 351-360
14. Braun A.R., Balkin T.J., Wesenten N.J., Carson R.E., Varga M., Baldwin P., et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 120 Pt 7 (1997) 1173-1197
15. Chartrel N., Conlon J.M., Collin F., Braun B., Waugh D., Vallarino M., et al. Urotensin II in the central nervous system of the frog Rana ridibunda. Biochemical characterization and immunohistochemical localization. Ann N Y Acad Sci 839 (1998) 506-507
16. Chartrel N., Leprince J., Dujardin C., Chatenet D., Tollemer H., Baroncini M., et al. Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord. J Neurochem 91 (2004) 110-118
17. Chatenet D., Dubessy C., Leprince J., Boularan C., Carlier L., Segalas-Milazzo I., et al. Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25 (2004) 1819-1830
18. Clark S.D., Alderson H.L., Winn P., Latimer M.P., Nothacker H.P., and Civelli O. Fusion of diphtheria toxin and urotensin II produces a neurotoxin selective for cholinergic neurons in the rat mesopontine tegmentum. J Neurochem 102 (2007) 112-120
19. Clark S.D., Nothacker H.P., Blaha C.D., Tyler C.J., Duangdao D.M., Grupke S.L., et al. Urotensin II acts as a modulator of mesopontine cholinergic neurons. Brain Res 1059 (2005) 139-148
20. Clark S.D., Nothacker H.P., Wang Z., Saito Y., Leslie F.M., and Civelli O. The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res 923 (2001) 120-127
21. Conlon J.M., Tostivint H., and Vaudry H. Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul Pept 69 (1997) 95-103
22. Conlon J.M., Yano K., Waugh D., and Hazon N. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J Exp Zool 275 (1996) 226-238
23. Coulouarn Y., Jegou S., Tostivint H., Vaudry H., and Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457 (1999) 28-32
24. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., et al. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95 (1998) 15803-15808
25. Coy D.H., Rossowski W.J., Cheng B.L., and Taylor J.E. Structural requirements at the N-terminus of urotensin II octapeptides. Peptides 23 (2002) 2259-2264
26. Datta S., Patterson E.H., and Spoley E.E. Excitation of the pedunculopontine tegmental NMDA receptors induces wakefulness and cortical activation in the rat. J Neurosci Res 66 (2001) 109-116
27. Datta S., and Siwek D.F. Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep-wake cycle in the freely moving rats. J Neurosci Res 70 (2002) 611-621
28. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95 (1998) 322-327
29. In: de Lecea L., and Sutcliffe J.G. (Eds). Hypocretins: integrators of physiological functions (2005), Springer, New York
30. Douglas S.A., Sulpizio A.C., Piercy V., Sarau H.M., Ames R.S., Aiyar N.V., et al. Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol 131 (2000) 1262-1274
31. Dun S.L., Brailoiu G.C., Yang J., Chang J.K., and Dun N.J. Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett 305 (2001) 9-12
32. el Kafi B., Cespuglio R., Leger L., Marinesco S., and Jouvet M. Is the nucleus raphe dorsalis a target for the peptides possessing hypnogenic properties?. Brain Res 637 (1994) 211-221
33. Fang J., Payne L., and Krueger J.M. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats. Brain Res 686 (1995) 23-28
34. Feinberg I., and Campbell I.G. Adenosine, blood pressure and NREM delta. Sleep 22 7 (1999) 9
35. Fields H.L., Hjelmstad G.O., Margolis E.B., and Nicola S.M. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci (2007)
36. Gartlon J., Parker F., Harrison D.C., Douglas S.A., Ashmeade T.E., Riley G.J., et al. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berlin) 155 (2001) 426-433
37. Gibson A., Wallace P., and Bern H.A. Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen Comp Endocrinol 64 (1986) 435-439
38. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 (1998) 265-270
39. Hobson J.A., McCarley R.W., and Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189 (1975) 55-58
40. Huitron-Resendiz S., Kristensen M.P., Sanchez-Alavez M., Clark S.D., Grupke S.L., Tyler C., et al. Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons. J Neurosci 25 (2005) 5465-5474
41. Jegou S., Cartier D., Dubessy C., Gonzalez B.J., Chatenet D., Tostivint H., et al. Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 495 (2006) 21-36
42. Krueger J.M., and Majde J.A. Humoral links between sleep and the immune system: research issues. Ann N Y Acad Sci 992 (2003) 9-20
43. Lee M.G., Hassani O.K., and Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 25 (2005) 6716-6720
44. Leonard C.S., and Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 59 (1994) 309-330
45. Lu J., Sherman D., Devor M., and Saper C.B. A putative flip-flop switch for control of REM sleep. Nature (2006)
46. Lydic R., and Baghdoyan H.A. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology 103 (2005) 1268-1295
47. Lydic R., Douglas C.L., and Baghdoyan H.A. Microinjection of neostigmine into the pontine reticular formation of C57BL/6J mouse enhances rapid eye movement sleep and depresses breathing. Sleep 25 (2002) 835-841
48. Mathis J., Hess C.W., and Bassetti C. Isolated mediotegmental lesion causing narcolepsy and rapid eye movement sleep behaviour disorder: a case evidencing a common pathway in narcolepsy and rapid eye movement sleep behaviour disorder. J Neurol Neurosurg Psychiatry 78 (2007) 427-429
49. Mileykovskiy B.Y., Kiyashchenko L.I., and Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46 (2005) 787-798
50. Mirmiran M., Kruisbrink J., Bos N.P., Van der Werf D., and Boer G.J. Decrease of rapid-eye-movement sleep in the light by intraventricular application of a VIP-antagonist in the rat. Brain Res 458 (1988) 192-194
51. Mitani A., Ito K., Hallanger A.E., Wainer B.H., Kataoka K., and McCarley R.W. Cholinergic projections from the laterodorsal and pedunculopontine tegmental nuclei to the pontine gigantocellular tegmental field in the cat. Brain Res 451 (1988) 397-402
52. Mori M., and Fujino M. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain. Peptides 25 (2004) 1815-1818
53. Mori M., Sugo T., Abe M., Shimomura Y., Kurihara M., Kitada C., et al. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265 (1999) 123-129
54. Narita M., Nagumo Y., Hashimoto S., Khotib J., Miyatake M., Sakurai T., et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26 (2006) 398-405
55. Nightingale S., Orgill J.C., Ebrahim I.O., de Lacy S.F., Agrawal S., and Williams A.J. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med 6 (2005) 253-258
56. Nothacker H.P., and Clark S. From heart to mind. The urotensin II system and its evolving neurophysiological role. FEBS J 272 (2005) 5694-5702
57. Nothacker H.P., Wang Z., McNeill A.M., Saito Y., Merten S., O'Dowd B., et al. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1 (1999) 383-385
58. Nunez A., Moreno-Balandran M.E., Rodrigo-Angulo M.L., Garzon M., and De Andres I. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. Eur J Neurosci 24 (2006) 2834-2842
59. Pace-Schott E.F., and Hobson J.A. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3 (2002) 591-605
60. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., et al. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 77 (1980) 5021-5024
61. Pelletier G., Lihrmann I., Dubessy C., Luu-The V., Vaudry H., and Labrie F. Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord. Neuroscience 132 (2005) 689-696
62. Petit J.M., Luppi P.H., Peyron C., Rampon C., and Jouvet M. VIP-like immunoreactive projections from the dorsal raphe and caudal linear raphe nuclei to the bed nucleus of the stria terminalis demonstrated by a double immunohistochemical method in the rat. Neurosci Lett 193 (1995) 77-80
63. Piper D.C., Upton N., Smith M.I., and Hunter A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 12 (2000) 726-730
64. Prospero-Garcia O., and Mendez-Diaz M. The role of neuropeptides in sleep modulation. Drug News Perspect 17 (2004) 518-522
65. Riou F., Cespuglio R., and Jouvet M. Hypnogenic properties of the vasoactive intestinal polypeptide in rats. C R Seances Acad Sci III 293 (1981) 679-682
66. Russell F.D., Molenaar P., and O'Brien D.M. Cardiostimulant effects of urotensin-II in human heart in vitro. Br J Pharmacol 132 (2001) 5-9
67. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
68. Shiromani P.J., Armstrong D.M., and Gillin J.C. Cholinergic neurons from the dorsolateral pons project to the medial pons: a WGA-HRP and choline acetyltransferase immunohistochemical study. Neurosci Lett 95 (1988) 19-23
69. Shouse M.N., and Siegel J.M. Pontine regulation of REM sleep components in cats: integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM sleep. Brain Res 571 (1992) 50-63
70. Steriade M., Datta S., Pare D., Oakson G., and Curro Dossi R.C. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J Neurosci 10 (1990) 2541-2559
71. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., et al. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310 (2003) 860-868
72. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3 (2002) 339-349
73. Thakkar M.M., Ramesh V., Cape E.G., Winston S., Strecker R.E., and McCarley R.W. REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation. Sleep Res Online 2 (1999) 112-120
74. Vanni-Mercier G., Sakai K., Lin J.S., and Jouvet M. Mapping of cholinoceptive brainstem structures responsible for the generation of paradoxical sleep in the cat. Arch Ital Biol 127 (1989) 133-164
75. Vazquez J., Lydic R., and Baghdoyan H.A. The nitric oxide synthase inhibitor NG-Nitro-l-arginine increases basal forebrain acetylcholine release during sleep and wakefulness. J Neurosci 22 (2002) 5597-5605
76. Webster H.H., and Jones B.E. Neurotoxic lesions of the dorsolateral pontomesencephalic tegmentum-cholinergic cell area in the cat. II. Effects upon sleep-waking states. Brain Res 458 (1988) 285-302
77. Williams J.A., Vincent S.R., and Reiner P.B. Nitric oxide production in rat thalamus changes with behavioral state, local depolarization, and brainstem stimulation. J Neurosci 17 (1997) 420-427
78. Xi M., Morales F.R., and Chase M.H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res 901 (2001) 259-264
79. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497